136.20SEK+0.15%Mkt Cap: 310.73M $P/E: 24.231d ago
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hemat…
Indicators:|
Key Statistics
Company
Market Cap310.73M $
Enterprise Value290.86M $
Revenue (TTM)69.88M $
Gross Profit49.73M $
Net Income (TTM)14.64M $
Revenue/Share2.930 USD
Last Price136.20 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees241
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)24.23
P/E (Forward)16.57
PEG—
EV/EBITDA15.66
EV/Revenue4.16
P/S4.45
P/B3.55
EPS (TTM)5.63
EPS (Forward)8.22
52W Range
117.6025% of range192.20
52W High192.20 SEK
52W Low117.60 SEK
Profitability
Gross Margin68.50%
Oper. Margin17.12%
EBITDA Margin26.57%
Profit Margin20.17%
ROE17.25%
ROA13.98%
Growth
Revenue Growth-14.60%
Earnings Growth-45.80%
Cash Flow & Leverage
Operating CF19.18M $
CapEx (TTM)8.25M $
FCF Margin12.31%
FCF Yield2.77%
Net Debt-19.88M $
Net Debt/EBITDA-1.07
Balance Sheet
Debt/Equity0.03
Current Ratio3.80
Quick Ratio2.82
Book Value/Sh38.33 SEK
Cash/Share9.652 SEK
Dividends
Fwd Div Rate2.750 SEK
Trail. Div Rate2.750 SEK
Div. Yield2.02%
5Y Avg Yield1.02%
Payout Ratio44.48%
Ex-Div DateApr 29, 2026
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)177.75 SEK
Upside (mean)+30.5%
Target Range140.00 SEK – 211.00 SEK
SEK140.00+30.5% to meanSEK211.00
# Analysts4
Ownership
Shares Out.23.85M
Float19.50M
Insiders16.92%
Institutions74.81%
Technical
SMA 50128.71 (+5.8%)
SMA 200151.82 (-10.3%)
Beta0.96
S&P 52W Chg20.05%
Avg Vol (30d)58.45K
Avg Vol (10d)38.11K
Technical Indicators
RSI (14)54.8
MACD2.7521
MACD Signal2.4566
MACD Hist.+0.2955
BB Upper148.68 SEK
BB Middle132.60 SEK
BB Lower116.52 SEK
BB Width24.25%
ATR (14)5.261 SEK
Vol Ratio (20d)0.24x